All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for CENTRIENT PHARMACEUTICALS LLC · Pharmaceutical Manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $50,000.00 income · posted Apr 21, 2025

Official filing document

Lobbying activity 4

Pharmacy

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Health Issues

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Manufacturing

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Defense

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States; Issues related to the Defense Production Act (DPA).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.